Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.94M | -3.42M | 30.57M | 28.33M | 18.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.94M | -3.42M | 30.57M | 28.33M | 18.43M |
| Cost of Revenue | 8.16M | -11.70M | 14.28M | 13.44M | 6.19M |
| Gross Profit | 15.79M | 8.27M | 16.30M | 14.89M | 12.24M |
| SG&A Expenses | 14.10M | 5.80M | 14.89M | 14.40M | 12.77M |
| Depreciation & Amortization | 702.00K | 3.00K | 910.00K | 910.00K | 688.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.16M | -4.81M | 32.13M | 31.12M | 21.73M |
| Operating Income | -1.22M | 1.39M | -1.56M | -2.80M | -3.30M |
| Income Before Tax | -434.00K | 1.54M | -1.73M | -7.15M | -3.18M |
| Income Tax Expenses | 14.00K | -131.00K | -28.00K | -- | 17.00K |
| Earnings from Continuing Operations | -448.00K | 1.67M | -1.70M | -7.15M | -3.20M |
| Earnings from Discontinued Operations | -- | 10.79M | -- | -13.57M | -7.02M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -448.00K | 12.46M | -1.70M | -20.72M | -10.22M |
| EBIT | -1.22M | 1.39M | -1.56M | -2.80M | -3.30M |
| EBITDA | 166.00K | 2.76M | 758.00K | -433.00K | -1.02M |
| EPS Basic | -0.01 | 0.27 | -0.04 | -0.45 | -0.23 |
| Normalized Basic EPS | -0.01 | 0.02 | -0.02 | -0.04 | -0.04 |
| EPS Diluted | -0.01 | 0.26 | -0.04 | -0.45 | -0.23 |
| Normalized Diluted EPS | -0.01 | 0.02 | -0.02 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 47.13M | 46.65M | 46.18M | 46.00M | 45.43M |
| Average Diluted Shares Outstanding | 47.13M | 48.03M | 46.18M | 46.00M | 45.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |